These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3885035)

  • 1. Intranasal aerosolized insulin. Mixed-meal studies and long-term use in type I diabetes.
    Salzman R; Manson JE; Griffing GT; Kimmerle R; Ruderman N; McCall A; Stoltz EI; Mullin C; Small D; Armstrong J
    N Engl J Med; 1985 Apr; 312(17):1078-84. PubMed ID: 3885035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term use of intranasal insulin in insulin-dependent diabetic patients.
    Frauman AG; Cooper ME; Parsons BJ; Jerums G; Louis WJ
    Diabetes Care; 1987; 10(5):573-8. PubMed ID: 3315514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Split-mixed insulin regimen with human ultralente before supper and NPH (isophane) before breakfast in children and adolescents with IDDM.
    Wolfsdorf JI; Laffel LM; Pasquarello C; Vernon A; Herskowitz RD
    Diabetes Care; 1991 Nov; 14(11):1100-6. PubMed ID: 1797498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of basal hepatic glucose production and fasting hyperglycemia of type I diabetic patients treated with human recombinant ultralente insulin.
    Riccio A; Avogaro A; Valerio A; Zappella A; Tiengo A; Del Prato S
    Diabetes Care; 1994 Jun; 17(6):535-40. PubMed ID: 8082521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal administration of lispro insulin in hyperglycemic type 1 diabetes.
    Rassam AG; Zeise TM; Burge MR; Schade DS
    Diabetes Care; 1999 Jan; 22(1):133-6. PubMed ID: 10333914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin administered intranasally as an insulin-bile salt aerosol. Effectiveness and reproducibility in normal and diabetic subjects.
    Moses AC; Gordon GS; Carey MC; Flier JS
    Diabetes; 1983 Nov; 32(11):1040-7. PubMed ID: 6357902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.
    Burge MR; Waters DL; Holcombe JH; Schade DS
    J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of optimal insulin administration timing for standard carbohydrates-rich meals using continuous glucose monitoring in children with type 1 diabetes: A cross-over randomized study.
    Tucholski K; Sokołowska M; Tucholska D; Kamińska H; Jarosz-Chobot P
    J Diabetes Investig; 2019 Sep; 10(5):1237-1245. PubMed ID: 30768859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal insulin therapy: the clinical realities.
    Hilsted J; Madsbad S; Hvidberg A; Rasmussen MH; Krarup T; Ipsen H; Hansen B; Pedersen M; Djurup R; Oxenbøll B
    Diabetologia; 1995 Jun; 38(6):680-4. PubMed ID: 7672489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart.
    Vague P; Selam JL; Skeie S; De Leeuw I; Elte JW; Haahr H; Kristensen A; Draeger E
    Diabetes Care; 2003 Mar; 26(3):590-6. PubMed ID: 12610006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of human ultralente- and lente-based twice-daily injection regimens.
    Tunbridge FK; Newens A; Home PD; Davis SN; Murphy M; Burrin JM; Alberti KG; Jensen I
    Diabet Med; 1989 Aug; 6(6):496-501. PubMed ID: 2527130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.
    Brown SA; Kovatchev BP; Raghinaru D; Lum JW; Buckingham BA; Kudva YC; Laffel LM; Levy CJ; Pinsker JE; Wadwa RP; Dassau E; Doyle FJ; Anderson SM; Church MM; Dadlani V; Ekhlaspour L; Forlenza GP; Isganaitis E; Lam DW; Kollman C; Beck RW;
    N Engl J Med; 2019 Oct; 381(18):1707-1717. PubMed ID: 31618560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skipping meals or carbohydrate-free meals in order to determine Basal insulin requirements in subjects with type 1 diabetes mellitus?
    Uthoff H; Lehmann R; Sprenger M; Wiesli P
    Exp Clin Endocrinol Diabetes; 2010 May; 118(5):325-7. PubMed ID: 20072961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled human insulin treatment in patients with type 2 diabetes mellitus.
    Cefalu WT; Skyler JS; Kourides IA; Landschulz WH; Balagtas CC; Cheng S; Gelfand RA;
    Ann Intern Med; 2001 Feb; 134(3):203-7. PubMed ID: 11177333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal insulin: the effects of three dose regimens on postprandial glycaemic profiles in type II diabetic subjects.
    Coates PA; Ismail IS; Luzio SD; Griffiths I; Ollerton RL; Vølund A; Owens DR
    Diabet Med; 1995 Mar; 12(3):235-9. PubMed ID: 7758260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemic variation and hypoglycemia in patients with well-controlled type 1 diabetes on a multiple daily insulin injection program with use of glargine and ultralente as basal insulin.
    Kudva YC; Basu A; Jenkins GD; Pons GM; Vogelsang DA; Rizza RA; Smith SA; Isley WL
    Endocr Pract; 2007; 13(3):244-50. PubMed ID: 17599855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Postprandial Glucose Control Using the InsuPad Device in Insulin-Treated Type 2 Diabetes: Injection Site Warming to Improve Glycemic Control.
    Raz I; Bitton G; Feldman D; Alon T; Pfutzner A; Tamborlane WV
    J Diabetes Sci Technol; 2015 May; 9(3):639-43. PubMed ID: 25883166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Energy intake and glycemia in lactating women with type 1 diabetes.
    Murtaugh MA; Ferris AM; Capacchione CM; Reece EA
    J Am Diet Assoc; 1998 Jun; 98(6):642-8. PubMed ID: 9627620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Titration of Long-Acting Insulin Using Continuous Glucose Monitoring and Smart Insulin Pens in Type 1 Diabetes: A Model-Based Carbohydrate-Free Approach.
    El Fathi A; Fabris C; Breton MD
    Front Endocrinol (Lausanne); 2021; 12():795895. PubMed ID: 35082757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.